These cancer-related phosphoproteins were enriched in pathways, including translation initiation (such as EIF4EBP1_T70 and EIF5B_S214), cell migration (such as CD44_S183 and ITGB4_S1387), and cell proliferation (such as STAT4_S715 and TP53BP1_S403) (Fig. 4D). This evidence concerns the gene CD44 and cancer.